Francisco J Zapatero-Belinchón

8PUBLICATIONS
63CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyMolecular medicineCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 20, 2026
NRF2 activators and the inhibitor of nuclear export, selinexor, restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1 through an NRF2-independent mechanism.

Fakhar H Waqas, Leandro Silva da Costa, Francisco J Zapatero-Belinchón

|Jan 06, 2026
Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models.

Luca Lizzadro, Jiapeng Li, Taha Y Taha

|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

|Aug 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

|Feb 07, 2024
Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.

Vania Passos, Lisa M Henkel, Jiayi Wang

|Jun 09, 2023
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase.

Isha Singh, Fengling Li, Elissa A Fink

Pageof 2

Frequent Collaborators

4 joint publications

Melanie Ott

4 joint publications

Adam R Renslo

4 joint publications

Brian K Shoichet

3 joint publications

Taha Y Taha